The efficacy and safety of lenvatinib plus pembrolizumab therapy in patients with uterine carcinosarcoma

The efficacy and safety of lenvatinib plus pembrolizumab therapy in patients with uterine carcinosarcoma

Lenvatinib plus pembrolizumab (LP) therapy is currently used in patients with advanced or recurrent endometrial cancer. However, patients with uterine carcinosarcoma (UCS) were not included in the KEYNOTE-775, and the efficacy of LP therapy for patients with UCS in clinical practice remains unclear....

Full description

Saved in:
Bibliographic Details
Main Authors: Risako Ozawa (Author), Tadaaki Nishikawa (Author), Kasumi Yamamoto (Author), Tatsunori Shimoi (Author), Mitsuya Ishikawa (Author), Tomoyasu Kato (Author), Kan Yonemori (Author)
Format: Book
Published: Elsevier, 2024-10-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items